---
title: KBI Biopharma, Inc. vs Rezon Bio
slug_a: kbibiopharma
slug_b: rezonbio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/kbibiopharma/rezonbio
---

# KBI Biopharma, Inc. vs Rezon Bio

Side-by-side profile data from each company listing on this directory.

## KBI Biopharma, Inc.

- Profile: [/companies/kbibiopharma](/companies/kbibiopharma)

KBI Biopharma, Inc. — Global CDMO offering cell line development, process and analytical development, formulation development, and clinical and commercial manufacturing for mammalian and microbial biologics.

Services: 13. Modalities: 2. Indications: 1. Locations: 11. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Process Development
- Formulation Development
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial
- Single-Use / Disposable

## Rezon Bio

- Profile: [/companies/rezonbio](/companies/rezonbio)

Rezon Bio — European biologics CDMO offering end-to-end development and manufacturing across two GMP-certified sites in Poland, with capabilities from cell line development to commercial-scale production.

Services: 9. Modalities: 2. Indications: 0. Locations: 4. Certifications: 2. The strongest documented coverage currently appears in services (9).

### Services

- Regulatory Affairs
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Development capabilities

- Analytical method development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Mammalian
- Stainless Steel